Concord Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2021
Cash & Equivalents	-	11.83	151.42	34.99	6.67	51.44	Upgrade
Short-Term Investments	-	3,165	228.22	305.8	872.5	550	Upgrade
Trading Asset Securities	-	-	2,437	1,369	734.73	1,410	Upgrade
Cash & Short-Term Investments	3,177	3,177	2,817	1,710	1,614	2,011	Upgrade
Cash Growth	12.80%	12.80%	64.71%	5.96%	-19.76%	0.31%	Upgrade
Accounts Receivable	-	5,217	3,496	2,738	2,322	1,775	Upgrade
Other Receivables	-	-	159.99	217.95	272.74	358.19	Upgrade
Receivables	-	5,217	3,656	2,956	2,594	2,133	Upgrade
Inventory	-	2,397	2,080	2,123	1,951	1,536	Upgrade
Prepaid Expenses	-	-	73.31	55.19	47.61	45.44	Upgrade
Other Current Assets	-	561.96	336.73	433.05	119.5	345.27	Upgrade
Total Current Assets	-	11,352	8,962	7,277	6,327	6,071	Upgrade
Property, Plant & Equipment	-	8,442	7,865	7,655	6,436	5,577	Upgrade
Long-Term Investments	-	187.26	20.7	79.25	2.56	3.66	Upgrade
Other Intangible Assets	-	11.22	3.2	1.98	35.77	64.18	Upgrade
Other Long-Term Assets	-	349.41	156.1	126.8	327.4	108.69	Upgrade
Total Assets	-	20,343	17,007	15,140	13,128	11,825	Upgrade
Accounts Payable	-	1,130	944.35	938	831.06	463.97	Upgrade
Accrued Expenses	-	-	168.21	146.19	131.45	102.38	Upgrade
Short-Term Debt	-	-	-	-	43.37	50.99	Upgrade
Current Portion of Long-Term Debt	-	3.81	62.3	250	250	250	Upgrade
Current Portion of Leases	-	19.58	16.21	1.47	15.96	13.01	Upgrade
Current Income Taxes Payable	-	101.27	54.94	89.99	-	-	Upgrade
Current Unearned Revenue	-	-	-	13.13	32.72	-	Upgrade
Other Current Liabilities	-	585.57	175.55	479.67	247.1	177.04	Upgrade
Total Current Liabilities	-	1,841	1,422	1,918	1,552	1,057	Upgrade
Long-Term Debt	-	-	-	62.36	312.49	562.5	Upgrade
Long-Term Leases	-	6.3	18.87	1.64	3.11	16.33	Upgrade
Long-Term Deferred Tax Liabilities	-	340.22	280.65	234.39	209.71	174.53	Upgrade
Other Long-Term Liabilities	-	28.2	19.56	22.97	18.74	20.98	Upgrade
Total Liabilities	-	2,215	1,741	2,240	2,096	1,832	Upgrade
Common Stock	-	104.62	104.62	104.62	95.11	95.11	Upgrade
Additional Paid-In Capital	-	-	819.71	819.71	829.22	829.22	Upgrade
Retained Earnings	-	-	14,342	11,976	10,108	9,069	Upgrade
Comprehensive Income & Other	-	18,023	-	-	-	-	Upgrade
Shareholders' Equity	18,127	18,127	15,266	12,900	11,032	9,994	Upgrade
Total Liabilities & Equity	-	20,343	17,007	15,140	13,128	11,825	Upgrade
Total Debt	29.69	29.69	97.38	315.46	624.93	892.83	Upgrade
Net Cash (Debt)	3,148	3,148	2,719	1,395	988.98	1,118	Upgrade
Net Cash Growth	15.75%	15.75%	94.98%	41.02%	-11.58%	-24.66%	Upgrade
Net Cash Per Share	30.08	30.08	25.99	13.33	9.45	10.69	Upgrade
Filing Date Shares Outstanding	104.65	104.61	104.62	104.62	104.62	104.62	Upgrade
Total Common Shares Outstanding	104.65	104.61	104.62	104.62	104.62	104.62	Upgrade
Working Capital	-	9,512	7,541	5,359	4,775	5,014	Upgrade
Book Value Per Share	173.25	173.28	145.93	123.31	105.45	95.53	Upgrade
Tangible Book Value	18,116	18,116	15,263	12,898	10,996	9,930	Upgrade
Tangible Book Value Per Share	173.14	173.18	145.90	123.29	105.11	94.91	Upgrade
Land	-	-	547.11	547.11	547.11	546.99	Upgrade
Buildings	-	-	2,576	2,463	2,226	1,981	Upgrade
Machinery	-	-	4,979	4,788	4,285	3,773	Upgrade
Construction In Progress	-	-	2,115	1,727	741.55	179.46	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.